Solving the cell therapy access problem – by reprogramming human cells
The idea of cell therapy is a new way to approach human health and usher in a new generation of treatments for diseases that have proved too complex for more established types of therapies – such as small molecules that normally come in the form of a pill. A cell therapy uses human cells as the treatment.
In the latest edition of Technology Dispatch, bit.bio SVP of Technical Operations & Cell Manufacturing, Kathryn Golden, shares her insight into the cell therapy access problem and how reprogramming human cells is the solution.
For bit.bio, synthetic biology is the redefining of biology to be more engineering focussed. opti-ox™ technology enables us to make this transition.